Cargando…

Conopeptides [V11L;V16D]ArIB and RgIA4: Powerful Tools for the Identification of Novel Nicotinic Acetylcholine Receptors in Monocytes

Venomous marine snails of the genus Conus employ small peptides to capture prey, mainly osteichthyes, mollusks, and worms. A subset of these peptides known as α-conotoxins, are antagonists of nicotinic acetylcholine receptors (nAChRs). These disulfide-rich peptides provide a large number of evolutio...

Descripción completa

Detalles Bibliográficos
Autores principales: Grau, Veronika, Richter, Katrin, Hone, Arik J., McIntosh, J. Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338043/
https://www.ncbi.nlm.nih.gov/pubmed/30687084
http://dx.doi.org/10.3389/fphar.2018.01499
_version_ 1783388390971932672
author Grau, Veronika
Richter, Katrin
Hone, Arik J.
McIntosh, J. Michael
author_facet Grau, Veronika
Richter, Katrin
Hone, Arik J.
McIntosh, J. Michael
author_sort Grau, Veronika
collection PubMed
description Venomous marine snails of the genus Conus employ small peptides to capture prey, mainly osteichthyes, mollusks, and worms. A subset of these peptides known as α-conotoxins, are antagonists of nicotinic acetylcholine receptors (nAChRs). These disulfide-rich peptides provide a large number of evolutionarily refined templates that can be used to develop conopeptides that are highly selective for the various nAChR subtypes. Two such conopeptides, namely [V11L;V16D]ArIB and RgIA4, have been engineered to selectively target mammalian α7(∗) and α9(∗) nAChRs, respectively, and have been used to study the functional roles of these subtypes in immune cells. Unlike in neurons and cochlear hair cells, where α7(∗) and α9(∗) nAChRs, respectively, function as ligand-gated ion channels, in immune cells ligand-evoked ion currents have not been demonstrated. Instead, different metabotropic functions of α7(∗) and α9(∗) nAChRs have been described in monocytic cells including the inhibition of ATP-induced ion currents, inflammasome activation, and interleukin-1β (IL-1β) release. In addition to conventional nAChR agonists, diverse compounds containing a phosphocholine group inhibit monocytic IL-1β release and include dipalmitoyl phosphatidylcholine, palmitoyl lysophosphatidylcholine, glycerophosphocholine, phosphocholine, phosphocholine-decorated lipooligosaccharides from Haemophilus influenzae, synthetic phosphocholine-modified bovine serum albumin, and the phosphocholine-binding C-reactive protein. In monocytic cells, the effects of [V11L;V16D]ArIB and RgIA4 suggested that activation of nAChRs containing α9, α7, and/or α10 subunits inhibits ATP-induced IL-1β release. These results have been corroborated utilizing gene-deficient mice and small interfering RNA. Targeted re-engineering of native α-conotoxins has resulted in excellent tools for nAChR research as well as potential therapeutics. (∗)indicates possible presence of additional subunits.
format Online
Article
Text
id pubmed-6338043
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63380432019-01-25 Conopeptides [V11L;V16D]ArIB and RgIA4: Powerful Tools for the Identification of Novel Nicotinic Acetylcholine Receptors in Monocytes Grau, Veronika Richter, Katrin Hone, Arik J. McIntosh, J. Michael Front Pharmacol Pharmacology Venomous marine snails of the genus Conus employ small peptides to capture prey, mainly osteichthyes, mollusks, and worms. A subset of these peptides known as α-conotoxins, are antagonists of nicotinic acetylcholine receptors (nAChRs). These disulfide-rich peptides provide a large number of evolutionarily refined templates that can be used to develop conopeptides that are highly selective for the various nAChR subtypes. Two such conopeptides, namely [V11L;V16D]ArIB and RgIA4, have been engineered to selectively target mammalian α7(∗) and α9(∗) nAChRs, respectively, and have been used to study the functional roles of these subtypes in immune cells. Unlike in neurons and cochlear hair cells, where α7(∗) and α9(∗) nAChRs, respectively, function as ligand-gated ion channels, in immune cells ligand-evoked ion currents have not been demonstrated. Instead, different metabotropic functions of α7(∗) and α9(∗) nAChRs have been described in monocytic cells including the inhibition of ATP-induced ion currents, inflammasome activation, and interleukin-1β (IL-1β) release. In addition to conventional nAChR agonists, diverse compounds containing a phosphocholine group inhibit monocytic IL-1β release and include dipalmitoyl phosphatidylcholine, palmitoyl lysophosphatidylcholine, glycerophosphocholine, phosphocholine, phosphocholine-decorated lipooligosaccharides from Haemophilus influenzae, synthetic phosphocholine-modified bovine serum albumin, and the phosphocholine-binding C-reactive protein. In monocytic cells, the effects of [V11L;V16D]ArIB and RgIA4 suggested that activation of nAChRs containing α9, α7, and/or α10 subunits inhibits ATP-induced IL-1β release. These results have been corroborated utilizing gene-deficient mice and small interfering RNA. Targeted re-engineering of native α-conotoxins has resulted in excellent tools for nAChR research as well as potential therapeutics. (∗)indicates possible presence of additional subunits. Frontiers Media S.A. 2019-01-07 /pmc/articles/PMC6338043/ /pubmed/30687084 http://dx.doi.org/10.3389/fphar.2018.01499 Text en Copyright © 2019 Grau, Richter, Hone and McIntosh. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Grau, Veronika
Richter, Katrin
Hone, Arik J.
McIntosh, J. Michael
Conopeptides [V11L;V16D]ArIB and RgIA4: Powerful Tools for the Identification of Novel Nicotinic Acetylcholine Receptors in Monocytes
title Conopeptides [V11L;V16D]ArIB and RgIA4: Powerful Tools for the Identification of Novel Nicotinic Acetylcholine Receptors in Monocytes
title_full Conopeptides [V11L;V16D]ArIB and RgIA4: Powerful Tools for the Identification of Novel Nicotinic Acetylcholine Receptors in Monocytes
title_fullStr Conopeptides [V11L;V16D]ArIB and RgIA4: Powerful Tools for the Identification of Novel Nicotinic Acetylcholine Receptors in Monocytes
title_full_unstemmed Conopeptides [V11L;V16D]ArIB and RgIA4: Powerful Tools for the Identification of Novel Nicotinic Acetylcholine Receptors in Monocytes
title_short Conopeptides [V11L;V16D]ArIB and RgIA4: Powerful Tools for the Identification of Novel Nicotinic Acetylcholine Receptors in Monocytes
title_sort conopeptides [v11l;v16d]arib and rgia4: powerful tools for the identification of novel nicotinic acetylcholine receptors in monocytes
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338043/
https://www.ncbi.nlm.nih.gov/pubmed/30687084
http://dx.doi.org/10.3389/fphar.2018.01499
work_keys_str_mv AT grauveronika conopeptidesv11lv16daribandrgia4powerfultoolsfortheidentificationofnovelnicotinicacetylcholinereceptorsinmonocytes
AT richterkatrin conopeptidesv11lv16daribandrgia4powerfultoolsfortheidentificationofnovelnicotinicacetylcholinereceptorsinmonocytes
AT honearikj conopeptidesv11lv16daribandrgia4powerfultoolsfortheidentificationofnovelnicotinicacetylcholinereceptorsinmonocytes
AT mcintoshjmichael conopeptidesv11lv16daribandrgia4powerfultoolsfortheidentificationofnovelnicotinicacetylcholinereceptorsinmonocytes